These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30805192)

  • 1. Successful management of pleural infection with very low dose intrapleural tissue plasminogen activator/deoxyribonuclease regime.
    Hart JA; Badiei A; Lee YCG
    Respirol Case Rep; 2019 Apr; 7(3):e00408. PubMed ID: 30805192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
    Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
    Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema.
    Innabi A; Surana A; Alzghoul B; Meena N
    Cureus; 2018 Feb; 10(2):e2214. PubMed ID: 30755840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
    Piccolo F; Popowicz N; Wong D; Lee YC
    J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection.
    Popowicz N; Piccolo F; Shrestha R; Lee YC
    Respirol Case Rep; 2014 Jun; 2(2):87-9. PubMed ID: 25473577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemothorax With White-Out Lung After Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy in a Patient With Complicated Parapneumonic Effusion.
    Mainali A; Adhikari S; Chowdhury T; Gousy N; Bisural R; Devkota S; Kaphle Bastola AD
    Cureus; 2022 Jun; 14(6):e26208. PubMed ID: 35891847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unintentional intramuscular administration of tPA/DNase for pleural infection.
    Popowicz N; Nash M; Lee YC
    Respirol Case Rep; 2014 Dec; 2(4):144-6. PubMed ID: 25530865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis.
    Barrett CD; Moore PK; Moore EE; Moore HB; Chandler JG; Siddiqui H; Maginot ER; Sauaia A; Pérez-Calatayud AA; Buesing K; Wang J; Davila-Chapa C; Hershberger D; Douglas I; Pieracci FM; Yaffe MB
    Chest; 2024 May; ():. PubMed ID: 38710463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
    Ahmed AH; Yacoub TE
    Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.